Cargando…
Targeted Secretion Inhibitors—Innovative Protein Therapeutics
Botulinum neurotoxins are highly effective therapeutic products. Their therapeutic success results from highly specific and potent inhibition of neurotransmitter release with a duration of action measured in months. These same properties, however, make the botulinum neurotoxins the most potent acute...
Autores principales: | Foster, Keith, Chaddock, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153183/ https://www.ncbi.nlm.nih.gov/pubmed/22069575 http://dx.doi.org/10.3390/toxins2122795 |
Ejemplares similares
-
Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors
por: Masuyer, Geoffrey, et al.
Publicado: (2015) -
Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer
por: Dervisis, Nikolaos, et al.
Publicado: (2016) -
Innovation and Application of the Type III Secretion System Inhibitors in Plant Pathogenic Bacteria
por: Yuan, Xiaochen, et al.
Publicado: (2020) -
Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008) -
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
por: Holanda, Victor A. D., et al.
Publicado: (2021)